Molecular Diagnosis of Chronic Granulomatous Disease

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2013 Sep 11

PMID 24016250

Citations 59

Authors

D Roos

M de Boer

Affiliations

Soon will be listed here.

Abstract

Patients with chronic granulomatous disease (CGD) suffer from recurrent, life-threatening bacterial and fungal infections of the skin, the airways, the lymph nodes, liver, brain and bones. Frequently found pathogens are Staphylococcus aureus, Aspergillus species, Klebsiella species, Burkholderia cepacia and Salmonella species. CGD is a rare (∼1:250 000 births) disease caused by mutations in any one of the five components of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in phagocytes. This enzyme generates superoxide and is essential for intracellular killing of pathogens by phagocytes. Molecular diagnosis of CGD involves measuring NADPH oxidase activity in phagocytes, measuring protein expression of NADPH oxidase components and mutation analysis of genes encoding these components. Residual oxidase activity is important to know for estimation of the clinical course and the chance of survival of the patient. Mutation analysis is mandatory for genetic counselling and prenatal diagnosis. This review summarizes the different assays available for the diagnosis of CGD, the precautions to be taken for correct measurements, the flow diagram to be followed, the assays for confirmation of the diagnosis and the determinations for carrier detection and prenatal diagnosis.

Citing Articles

Mononuclear Phagocytes, Cellular Immunity, and Nobel Prizes: A Historic Perspective.

Gordon S, Roberti A, Kaufmann S Cells. 2024; 13(16).

PMID: 39195266 PMC: 11352343. DOI: 10.3390/cells13161378.

Diagnosis of Chronic Granulomatous Disease: Strengths and Challenges in the Genomic Era.

ODonovan C, Tan L, Abidin M, Roderick M, Grammatikos A, Bernatoniene J J Clin Med. 2024; 13(15).

PMID: 39124702 PMC: 11313294. DOI: 10.3390/jcm13154435.

Chronic Granulomatous Disease (CGD): Commonly Associated Pathogens, Diagnosis and Treatment.

Justiz-Vaillant A, Williams-Persad A, Arozarena-Fundora R, Gopaul D, Soodeen S, Asin-Milan O Microorganisms. 2023; 11(9).

PMID: 37764077 PMC: 10534792. DOI: 10.3390/microorganisms11092233.

Molecular Challenges in the Diagnosis of X-Linked Chronic Granulomatous Disease: CNVs, Intronic Variants, Skewed X-Chromosome Inactivation, and Gonosomal Mosaicism.

Batlle-Maso L, Riviere J, Franco-Jarava C, Martin-Nalda A, Garcia-Prat M, Parra-Martinez A J Clin Immunol. 2023; 43(8):1953-1963.

PMID: 37597073 DOI: 10.1007/s10875-023-01556-x.

Inflammation and Neutrophil Oxidative Burst in a Family with NFKB1 p.R157X LOF and Sterile Necrotizing Fasciitis.

Santaniemi W, Astrom P, Glumoff V, Pernaa N, Tallgren E, Palosaari S J Clin Immunol. 2023; 43(5):1007-1018.

PMID: 36892687 PMC: 10276129. DOI: 10.1007/s10875-023-01461-3.

References

Reeves E, Lu H, Jacobs H, Messina C, Bolsover S, Gabella G . Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002; 416(6878):291-7. DOI: 10.1038/416291a. View

Ahlin A, Fugelang J, de Boer M, Ringden O, Fasth A, Winiarski J . Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment. Acta Paediatr. 2013; 102(11):1087-94. DOI: 10.1111/apa.12384. View

Seger R, Gungor T, Belohradsky B, Blanche S, Bordigoni P, Di Bartolomeo P . Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood. 2002; 100(13):4344-50. DOI: 10.1182/blood-2002-02-0583. View

de Boer M, Bolscher B, Sijmons R, Scheffer H, Weening R, Roos D . Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction. Prenat Diagn. 1992; 12(9):773-7. DOI: 10.1002/pd.1970120910. View

Chanock S, Faust L, Barrett D, Bizal C, Maly F, Newburger P . O2- production by B lymphocytes lacking the respiratory burst oxidase subunit p47phox after transfection with an expression vector containing a p47phox cDNA. Proc Natl Acad Sci U S A. 1992; 89(21):10174-7. PMC: 50300. DOI: 10.1073/pnas.89.21.10174. View

Dahlgren C, Karlsson A, Bylund J . Measurement of respiratory burst products generated by professional phagocytes. Methods Mol Biol. 2008; 412:349-63. DOI: 10.1007/978-1-59745-467-4_23. View

Stasia M, van Leeuwen K, de Boer M, Martel C, Mollin M, Thuret I . Rare duplication or deletion of exons 6, 7 and 8 in CYBB leading to X-linked chronic granulomatous disease in two patients from different families. J Clin Immunol. 2012; 32(4):653-62. DOI: 10.1007/s10875-012-9667-2. View

Ambruso D, Knall C, Abell A, Panepinto J, Kurkchubasche A, Thurman G . Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A. 2000; 97(9):4654-9. PMC: 18288. DOI: 10.1073/pnas.080074897. View

Malech H, Maples P, Whiting-Theobald N, Linton G, Sekhsaria S, Vowells S . Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci U S A. 1997; 94(22):12133-8. PMC: 23727. DOI: 10.1073/pnas.94.22.12133. View

10.

Dekker J, de Boer M, Roos D . Gene-scan method for the recognition of carriers and patients with p47(phox)-deficient autosomal recessive chronic granulomatous disease. Exp Hematol. 2001; 29(11):1319-25. DOI: 10.1016/s0301-472x(01)00731-7. View

11.

Hill H, Augustine N, Pryor R, Reed G, Bagnato J, Tebo A . Rapid genetic analysis of x-linked chronic granulomatous disease by high-resolution melting. J Mol Diagn. 2010; 12(3):368-76. PMC: 2860474. DOI: 10.2353/jmoldx.2010.090147. View

12.

Stasia M, Mollin M, Martel C, Satre V, Coutton C, Amblard F . Functional and genetic characterization of two extremely rare cases of Williams-Beuren syndrome associated with chronic granulomatous disease. Eur J Hum Genet. 2013; 21(10):1079-84. PMC: 3778347. DOI: 10.1038/ejhg.2012.310. View

13.

Roos D, de Boer M, Koker M, Dekker J, Singh-Gupta V, Ahlin A . Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase. Hum Mutat. 2006; 27(12):1218-29. DOI: 10.1002/humu.20413. View

14.

Vowells S, Fleisher T, Sekhsaria S, Alling D, Maguire T, Malech H . Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr. 1996; 128(1):104-7. DOI: 10.1016/s0022-3476(96)70437-7. View

15.

Newburger P, Cohen H, Rothchild S, Hobbins J, Malawista S, Mahoney M . Prenatal diagnosis of chronic granulomatous disease. N Engl J Med. 1979; 300(4):178-81. DOI: 10.1056/NEJM197901253000406. View

16.

Ho C, Vowels M, LOCKWOOD L, Ziegler J . Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant. 1996; 18(1):213-5. View

17.

Shinawi M, Cheung S . The array CGH and its clinical applications. Drug Discov Today. 2008; 13(17-18):760-70. DOI: 10.1016/j.drudis.2008.06.007. View

18.

Koker M, Sanal O, Van Leeuwen K, de Boer M, Metin A, Patiroglu T . Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations. Eur J Clin Invest. 2009; 39(10):942-51. DOI: 10.1111/j.1365-2362.2009.02195.x. View

19.

Elloumi H, Holland S . Diagnostic assays for chronic granulomatous disease and other neutrophil disorders. Methods Mol Biol. 2008; 412:505-23. DOI: 10.1007/978-1-59745-467-4_31. View

20.

Di Matteo G, Giordani L, Finocchi A, Ventura A, Chiriaco M, Blancato J . Molecular characterization of a large cohort of patients with Chronic Granulomatous Disease and identification of novel CYBB mutations: an Italian multicenter study. Mol Immunol. 2009; 46(10):1935-41. DOI: 10.1016/j.molimm.2009.03.016. View